Health Care & Life Sciences » Pharmaceuticals | OncoVista Innovative Therapies Inc.

OncoVista Innovative Therapies Inc.

OncoVista Innovative Therapies Inc.
Stock Exchange Other OTC
EPS
$0.14
Market Cap
$376.94 K
Shares Outstanding
23.56 M
Public Float
-

Profile

Address
14785 Omicron Drive
San Antonio Texas 78245
United States
Employees -
Website -
Updated 07/08/2019
OncoVista Innovative Therapies, Inc. is a drug development company, which engages in the development and commercialization of targeted cancer therapies. The company produces drug discovery, registration strategies, and emerging technologies. Its products include Cordycepin and L-Nucleoside Conjugate.

Financials

View All

Alexander L. Weis
President, Chief Executive & Financial Officer